Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 2/20 | 0.57 |
| ▸ | CTSB | P07858 | 2/20 | 0.57 |
| ▸ | CTSS | P25774 | 2/20 | 0.57 |
| ▸ | AKT1 | P31749 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.51 |
| ▸ | MTOR | P42345 | 2/20 | 0.49 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23978843 | 0.83 | CTSL (0.55) | CTSLCTSBCTSSAKT1NPC1 | |
| SCHEMBL19742566 | 0.80 | CTSL (0.57) | CTSLCTSBCTSSAKT1NPC1 | |
| SCHEMBL29019161 | 0.80 | PPARA (0.53) | CTSLCTSBCTSSAKT1 | |
| SCHEMBL29019158 | 0.80 | PPARA (0.53) | CTSLCTSBCTSSAKT1 | |
| SCHEMBL1007764 | 0.80 | KMT2A (0.62) | CTSLCTSBCTSSAKT1NPC1 | |
| SCHEMBL1007763 | 0.80 | KMT2A (0.62) | CTSLCTSBCTSSAKT1NPC1 | |
| SCHEMBL7797088 | 0.79 | AKT1 (0.63) | CTSLCTSBCTSSAKT1NPC1 | |
| SCHEMBL24803336 | 0.79 | SYK (0.52) | CTSLCTSBCTSSSYK | |
| SCHEMBL23978700 | 0.79 | SYK (0.52) | CTSLCTSBCTSSSYK | |
| SCHEMBL7190668 | 0.79 | RIPK1 (0.57) | CTSLCTSBCTSSAKT1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215783-A1 | COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION | CHOONGWAE PHARMA CORPORATION (KR) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215783-A1 | COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION | MYLK2, TNNC1, MYH2 | CTSL 2885/4885CTSB 237/4885CTSS 1308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.